Immunomodulation by fish-oil containing lipid emulsions in murine acute respiratory distress syndrome

Critical Care

Volumn 18, Issue 2, 2014, Pages

  Hecker, Matthias ^a   Ott, Juliane ^a   Sondermann, Christoph ^a   Schaefer, Martina B ^a   Obert, Martin ^b   Hecker, Andreas ^b   Morty, Rory E ^c   Vadasz, Istvan ^a   Herold, Susanne ^a   Rosengarten, Bernhard ^d   Witzenrath, Martin ^e   Seeger, Werner ^a   Mayer, Konstantin ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

^c MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^d JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FISH OIL; LIPID EMULSION; LIPOPOLYSACCHARIDE; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; MYELOPEROXIDASE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; SODIUM CHLORIDE;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INVASION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CYTOKINE PRODUCTION; EMULSION; HISTOLOGY; IMMUNOMODULATION; LEUKOCYTE; LEUKOCYTE COUNT; LUNG; LUNG ALVEOLUS; LUNG INJURY; MORPHOLOGY; MOUSE; NONHUMAN; PARENTERAL NUTRITION; PRIORITY JOURNAL; RISK ASSESSMENT; ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; RESPIRATORY DISTRESS SYNDROME, ADULT;

ANIMALS; DISEASE MODELS, ANIMAL; FAT EMULSIONS, INTRAVENOUS; FISH OILS; IMMUNOMODULATION; LEUKOCYTES; MICE; MICE, INBRED BALB C; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84903898622     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13850     Document Type: Article

References (41)

1. Hecker M, Walmrath HD, Seeger W, Mayer K. Clinical aspects of acute lung insufficiency (ALI/TRALI). Transfus Med Hemother 2008, 35:80-88.
2. Brun-Buisson C, Minelli C, Bertolini G, Brazzi L, Pimentel J, Lewandowski K, Bion J, Romand JA, Villar J, Thorsteinsson A, Damas P, Armaganidis A, Lemaire F, . ALIVE Study Group Epidemiology and outcome of acute lung injury in European intensive care units, results from the ALIVE study. Intensive Care Med 2004, 30:51-61. ALIVE Study Group.
3. Esteban A, Anzueto A, Frutos F, Alía I, Brochard L, Stewart TE, Benito S, Epstein SK, Apezteguía C, Nightingale P, Arroliga AC, Tobin MJ, . Mechanical Ventilation International Study Group Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA 2002, 287:345-355. Mechanical Ventilation International Study Group.
4. Matthay MA, Zimmerman GA. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 2005, 33:319-327.
5. Heller AR, Rossler S, Litz RJ, Stehr SN, Heller SC, Koch R, Koch T. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med 2006, 34:972-979.
6. Mayer K, Seeger W. Fish oil in critical illness. Curr Opin Clin Nutr Metab Care 2008, 11:121-127.
7. Wanten GJ, Calder PC. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr 2007, 85:1171-1184.
8. Wicklmayr M, Rett K, Dietze G, Mehnert H. Comparison of metabolic clearance rates of MCT/LCT and LCT emulsions in diabetics. JPEN J Parenter Enteral Nutr 1988, 12:68-71.
9. Dawes RF, Royle GT, Dennison AR, Crowe PJ, Ball M. Metabolic studies of a lipid emulsion containing medium-chain triglyceride in perioperative and total parenteral nutrition infusions. World J Surg 1986, 10:38-46.
10. Bach AC, Storck D, Meraihi Z. Medium-chain triglyceride-based fat emulsions: an alternative energy supply in stress and sepsis. JPEN J Parenter Enteral Nutr 1988, 12:82S-88S.
11. Pontes-Arruda A, Martins LF, de Lima SM, Isola AM, Toledo D, Rezende E, Maia M, Magnan GB. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in the early treatment of sepsis: results from a multicenter, prospective, randomized, double-blinded, controlled study: the INTERSEPT Study. Crit Care 2011, 15:R144.
12. Rice TW, Wheeler AP, Thompson BT, de Boisblanc BP, Steingrub J, Rock P, . NIH NHLBI Acute Respiratory Distress Syndrome Network of Investigators Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA 2011, 306:1574-1581. Erratum in: JAMA 2012, 307:563, NIH NHLBI Acute Respiratory Distress Syndrome Network of Investigators.
13. Schaefer MB, Ott J, Mohr A, Bi MH, Grosz A, Weissmann N, Ishii S, Grimminger F, Seeger W, Mayer K. Immunomodulation by n-3- versus n-6-rich lipid emulsions in murine acute lung injury-role of platelet-activating factor receptor. Crit Care Med 2007, 35:544-554.
14. Mayer K, Meyer S, Reinholz-Muhly M, Maus U, Merfels M, Lohmeyer J, Grimminger F, Seeger W. Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans. J Immunol 2003, 171:4837-4843.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
16. Hecker M, Zaslona Z, Kwapiszewska G, Niess G, Zakrzewicz A, Hergenreider E, Wilhelm J, Marsh LM, Sedding D, Klepetko W, Lohmeyer J, Dimmeler S, Seeger W, Weissmann N, Schermuly RT, Kneidinger N, Eickelberg O, Morty RE. Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension. Am J Respir Crit Care Med 2010, 182:805-818.
17. Mayer K, Kiessling A, Ott J, Schaefer MB, Hecker M, Henneke I, Schulz R, Gunther A, Wang J, Wu L, Roth J, Seeger W, Kang JX. Acute lung injury is reduced in fat-1 mice endogenously synthesizing n-3 fatty acids. Am J Respir Crit Care Med 2009, 179:474-483.
18. Singer P, Shapiro H, Theilla M, Anbar R, Singer J, Cohen J. Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med 2008, 34:1580-1592.
19. Sperling RI, Benincaso AI, Knoell CT, Larkin JK, Austen KF, Robinson DR. Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 1993, 91:651-660.
20. Schaefer MB, Wenzel A, Fischer T, Braun-Dullaeus RC, Renner F, Dietrich H, Schaefer CA, Seeger W, Mayer K. Fatty acids differentially influence phosphatidylinositol 3-kinase signal transduction in endothelial cells: impact on adhesion and apoptosis. Atherosclerosis 2008, 197:630-637.
21. Denys A, Hichami A, Khan NA. n-3 PUFAs modulate T-cell activation via protein kinase C-alpha and -epsilon and the NF-kappaB signaling pathway. J Lipid Res 2005, 46:752-758.
22. Camandola S, Leonarduzzi G, Musso T, Varesio L, Carini R, Scavazza A, Chiarpotto E, Baeuerle PA, Poli G. Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem Biophys Res Commun 1996, 229:643-647.
23. Weber C, Erl W, Pietsch A, Danesch U, Weber PC. Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 1995, 15:622-628.
24. Mayer K, Merfels M, Muhly-Reinholz M, Gokorsch S, Rosseau S, Lohmeyer J, Schwarzer N, Krull M, Suttorp N, Grimminger F, Seeger W. Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. Am J Physiol Heart Circ Physiol 2002, 283:H811-H818.
25. Prescott SM, Zimmerman GA, McIntyre TM. Platelet-activating factor. J Biol Chem 1990, 265:17381-17384.
26. Smith DF, Deem TL, Bruce AC, Reutershan J, Wu D, Ley K. Leukocyte phosphoinositide-3 kinase gamma is required for chemokine-induced, sustained adhesion under flow in vivo. J Leukoc Biol 2006, 80:1491-1499.
27. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002, 196:1025-1037.
28. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 2000, 192:1197-1204.
29. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008, 8:349-361.
30. Bach AC, Babayan VK. Medium-chain triglycerides: an update. Am J Clin Nutr 1982, 36:950-962.
31. Wanten GJ, Geijtenbeek TB, Raymakers RA, van Kooyk Y, Roos D, Jansen JB, Naber AH. Medium-chain, triglyceride-containing lipid emulsions increase human neutrophil beta2 integrin expression, adhesion, and degranulation. JPEN J Parenter Enteral Nutr 2000, 24:228-233.
32. Versleijen M, Roelofs H, Preijers F, Roos D, Wanten G. Parenteral lipids modulate leukocyte phenotypes in whole blood, depending on their fatty acid composition. Clin Nutr 2005, 24:822-829.
33. Wanten GJ, Curfs JH, Meis JF, Naber AH. Phagocytosis and killing of Candida albicans by human neutrophils after exposure to structurally different lipid emulsions. JPEN J Parenter Enteral Nutr 2001, 25:9-13.
34. Grau T, Ruiz de Adana JC, Zubillaga S, Fuerte S, Girón C. Randomized study of two different fat emulsions in total parenteral nutrition of malnourished surgical patients;effect of infectious morbidity and mortality. Nutr Hosp 2003, 18:159-166.
35. Lekka ME, Liokatis S, Nathanail C, Galani V, Nakos G. The impact of intravenous fat emulsion administration in acute lung injury. Am J Respir Crit Care Med 2004, 169:638-644.
36. Wang X, Li W, Li N, Li J. Omega-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study. JPEN J Parenter Enteral Nutr 2008, 32:236-241.
37. Barbosa VM, Miles EA, Calhau C, Lafuente E, Calder PC. Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care 2010, 14:R5.
38. Gadek JE, DeMichele SJ, Karlstad MD, Pacht ER, Donahoe M, Albertson TE, Van Hoozen C, Wennberg AK, Nelson JL, Noursalehi M. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome, Enteral Nutrition in ARDS Study Group. Crit Care Med 1999, 27:1409-1420.
39. Pontes-Arruda A, Aragao AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 2006, 34:2325-2333.
40. Felbinger TW, Weigand MA, Mayer K. Supplementation in acute lung injury. JAMA 2012, 307:144. author reply 145-146.
41. Stapleton RD, Martin TR, Weiss NS, Crowley JJ, Gundel SJ, Nathens AB, Akhtar SR, Ruzinski JT, Caldwell E, Curtis JR, Heyland DK, Watkins TR, Parsons PE, Martin JM, Wurfel MM, Hallstrand TS, Sims KA, Neff MJ. A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med 2011, 39:1655-1662.